Published in Blood Weekly, May 18th, 2006
Study 1: Autotransplantation increases the 3-year survival for acute myeloid leukemia patients in first or second remission.
"Most acute myeloid leukemia (AML) patients lack human leukocyte antigen-identical sibling donors for transplantation. Autotransplants and unrelated donor (URD) transplants are therapeutic options," researchers in the United States report.
"To compare autologous versus URD transplantation for AML in first (CR1) or second complete remission (CR2), we studied the outcomes of 668 autotransplants were compared with 476...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.